跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MYRELEZ 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MYRELEZ 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
MYRELEZ 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Amdipharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 23, 2021
Approval ID
febb283f9a6620c5
Company
Amdipharm Limited
Type
Standard
Approval Details
Approval Id
febb283f9a6620c5
Drug Cima Aemps Name
MYRELEZ 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
86176
Holder Company Name
Amdipharm Limited
Marketing Company Name
Advanz Pharma Spain S.L.U.
Holder Company Detail Path
/organization/amdipharm-limited
Authorization Date
2021-08-23
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
60 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Amdipharm Limited
Company Detail Path
/organization/amdipharm-limited
Company Information
Pharmaceutical Company Name
Amdipharm Limited
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Active Ingredients
LANREOTIDA ACETATO
66,67 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 23, 2021
Approval ID
febb283f9a6620c5
Type
Standard
Back to CIMA-AEMPS Approvals